TGFB1 and Myocardial fibrosis: Fe Shu and collaborators demonstrated that Icariside II chronic treatment (4, 8, and 16 mg/kg) reduces myocardial fibrosis in spontaneously hypertensive rats through suppression of NF-κB signaling and the TGF-b1/Smad2 signaling pathways [106].